Royal Bank of Canada’s Alaunos Therapeutics TCRT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-100
| Closed | – | – | 6868 |
|
|
2025
Q1 | $0 | Sell |
100
-8
| -7% | – | ﹤0.01% | 6668 |
|
|
2024
Q4 | $0 | Buy |
+108
| New | – | ﹤0.01% | 6640 |
|
|
2024
Q3 | – | Sell |
-35
| Closed | – | – | 6892 |
|
|
2024
Q2 | $0 | Buy |
35
+30
| +600% | – | ﹤0.01% | 7010 |
|
|
2024
Q1 | $0 | Sell |
5
-5
| -50% | – | ﹤0.01% | 6961 |
|
|
2023
Q4 | $0 | Sell |
10
-494
| -98% | – | ﹤0.01% | 6945 |
|
|
2023
Q3 | $10K | Buy |
504
+496
| +6,200% | +$9.84K | ﹤0.01% | 5927 |
|
|
2023
Q2 | $1K | Buy |
8
+3
| +60% | +$375 | ﹤0.01% | 6624 |
|
|
2023
Q1 | $0 | Buy |
5
+3
| +150% | – | ﹤0.01% | 6929 |
|
|
2022
Q4 | $0 | Sell |
2
-118
| -98% | – | ﹤0.01% | 7146 |
|
|
2022
Q3 | $31K | Buy |
120
+63
| +111% | +$16.3K | ﹤0.01% | 5478 |
|
|
2022
Q2 | $10K | Sell |
57
-84
| -60% | -$14.7K | ﹤0.01% | 5927 |
|
|
2022
Q1 | $13K | Sell |
141
-199
| -59% | -$18.3K | ﹤0.01% | 6354 |
|
|
2021
Q4 | $56K | Buy |
340
+164
| +93% | +$27K | ﹤0.01% | 5781 |
|
|
2021
Q3 | $48K | Buy |
176
+26
| +17% | +$7.09K | ﹤0.01% | 5674 |
|
|
2021
Q2 | $60K | Buy |
150
+3
| +2% | +$1.2K | ﹤0.01% | 5424 |
|
|
2021
Q1 | $80K | Buy |
147
+47
| +47% | +$25.6K | ﹤0.01% | 5120 |
|
|
2020
Q4 | $38K | Sell |
100
-5
| -5% | -$1.9K | ﹤0.01% | 5225 |
|
|
2020
Q3 | $40K | Sell |
105
-2
| -2% | -$762 | ﹤0.01% | 4956 |
|
|
2020
Q2 | $53K | Buy |
107
+14
| +15% | +$6.94K | ﹤0.01% | 4738 |
|
|
2020
Q1 | $34K | Buy |
93
+43
| +86% | +$15.7K | ﹤0.01% | 4829 |
|
|
2019
Q4 | $36K | Sell |
50
-90
| -64% | -$64.8K | ﹤0.01% | 5011 |
|
|
2019
Q3 | $90K | Sell |
140
-68
| -33% | -$43.7K | ﹤0.01% | 4275 |
|
|
2019
Q2 | $182K | Buy |
208
+56
| +37% | +$49K | ﹤0.01% | 3968 |
|
|
2019
Q1 | $88K | Buy |
152
+33
| +28% | +$19.1K | ﹤0.01% | 4240 |
|
|
2018
Q4 | $33K | Sell |
119
-115
| -49% | -$31.9K | ﹤0.01% | 4638 |
|
|
2018
Q3 | $113K | Buy |
234
+51
| +28% | +$24.6K | ﹤0.01% | 4205 |
|
|
2018
Q2 | $83K | Buy |
183
+10
| +6% | +$4.54K | ﹤0.01% | 4330 |
|
|
2018
Q1 | $101K | Buy |
173
+5
| +3% | +$2.92K | ﹤0.01% | 4097 |
|
|
2017
Q4 | $105K | Sell |
168
-64
| -28% | -$40K | ﹤0.01% | 4067 |
|
|
2017
Q3 | $214K | Buy |
232
+75
| +48% | +$69.2K | ﹤0.01% | 3778 |
|
|
2017
Q2 | $147K | Sell |
157
-21
| -12% | -$19.7K | ﹤0.01% | 3853 |
|
|
2017
Q1 | $170K | Sell |
178
-78
| -30% | -$74.5K | ﹤0.01% | 3824 |
|
|
2016
Q4 | $206K | Buy |
256
+88
| +52% | +$70.8K | ﹤0.01% | 3751 |
|
|
2016
Q3 | $143K | Buy |
168
+40
| +31% | +$34K | ﹤0.01% | 3913 |
|
|
2016
Q2 | $105K | Buy |
128
+20
| +19% | +$16.4K | ﹤0.01% | 4086 |
|
|
2016
Q1 | $120K | Hold |
108
| – | – | ﹤0.01% | 4010 |
|
|
2015
Q4 | $134K | Buy |
108
+2
| +2% | +$2.48K | ﹤0.01% | 4083 |
|
|
2015
Q3 | $143K | Buy |
106
+91
| +607% | +$123K | ﹤0.01% | 3973 |
|
|
2015
Q2 | $27K | Sell |
15
-28
| -65% | -$50.4K | ﹤0.01% | 5057 |
|
|
2015
Q1 | $70K | Buy |
43
+13
| +43% | +$21.2K | ﹤0.01% | 4357 |
|
|
2014
Q4 | $23K | Buy |
30
+17
| +131% | +$13K | ﹤0.01% | 4780 |
|
|
2014
Q3 | $5K | Sell |
13
-17
| -57% | -$6.54K | ﹤0.01% | 5091 |
|
|
2014
Q2 | $18K | Sell |
30
-138
| -82% | -$82.8K | ﹤0.01% | 4734 |
|
|
2014
Q1 | $115K | Buy |
168
+11
| +7% | +$7.53K | ﹤0.01% | 3973 |
|
|
2013
Q4 | $102K | Sell |
157
-13
| -8% | -$8.45K | ﹤0.01% | 3959 |
|
|
2013
Q3 | $101K | Buy |
170
+3
| +2% | +$1.78K | ﹤0.01% | 3927 |
|
|
2013
Q2 | $53K | Buy |
+167
| New | +$53K | ﹤0.01% | 4054 |
|